Psoriasis
Tissue Model
Human 3D
(NHu-3D)
Psoriasis
Tissue Model
NEW
Organotypic Model for Pre-clinical Drug Screening!
- Human 3D Model of Psoriatic Tissue
- Fully Differentiated, Ready-To-Use
- Unsurpassed Tissue Reproducibility
- Quantifiable, Objective Endpoints
- Cost Effective Pre-clinical Drug Testing
Attributes
Increased Expression of:
- Ki67
- HBD2
- Psoriasis
- Elafin
- Calgranulin C
- Cytokeratin 16
- And More
Decreased Expression of:
Increased Secretion of:
- IL-6
- IL-8
- GM-CSF
- And More
The Psoriasis Tissue Model is responsive to treatment with anti-psoriatic
compounds in a dose dependent manner.
Receive a copy of Technical Reference 702 - Development and
Characterization of a 3D Psoriatic Tissue Model here.
Drug Discovery, Development, Delivery & Toxicology Tools
Standardized Human 3D in vitro
Tissue Models
Home > 공지사항 
이전글
다음글
